<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.iongenomics.bio/p/grail-hit-with-shareholder-class</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-12T20:30:09+00:00</news:publication_date><news:title>Grail Hit with Shareholder Class Action Suit Over NHS-Galleri Trial Remarks</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/university-of-exeter-to-profile-epigenetics</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-12T20:07:32+00:00</news:publication_date><news:title>University of Exeter to Profile Epigenetics of UK Biobank Samples with Illumina Tech</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/all-things-q1-with-wall-street-analyst</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-12T14:53:07+00:00</news:publication_date><news:title>All Things Q1 with Wall Street Analyst Kyle Mikson</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/fda-approves-guardant-test-as-companion</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-11T21:34:04+00:00</news:publication_date><news:title>FDA Approves Guardant Test as Companion Diagnostic for First-Line Lung Cancer Drug</news:title></news:news></url></urlset>